Breast Cancer Clinical Trial
Official title:
Theory-based Training to Promote Breast Cancer Screening Among Women With Breast Cancer Worries: Randomized Controlled Trial
BACKGROUND: Breast cancer worries are important determinants in relation to behavior favoring
breast cancer screening.
OBJECTIVE: To determine the effect of theory-based training to promote breast cancer
screening among women with high and low levels of breast cancer worries.
DESIGN AND SETTING: Randomized controlled trial, conducted in two family health centers.
METHODS: In total, 285 women were recruited. Women with low levels of breast cancer worries
were included in the first intervention group (112 women) and the first control group (112
women), while women with high levels of breast cancer worries were included in the second
intervention group (37 women) and the second control group (43 women). Theory-based training
to promote breast cancer screening was given to intervention groups. The women's willingness
to undergo breast cancer screening and breast cancer worry scores were evaluated at 1, 3 and
6 months.
Breast cancer is the most frequent type of cancer and the most common cause of cancer death
among gynecological cancers. One in every four women with cancer in the world has breast
cancer. The International Cancer Agency reported that there were around 2,088,849 new cases
and 626,679 deaths due to breast cancer worldwide in 2018. The incidence of breast cancer is
higher in developed countries than in developing countries, but the numbers of deaths due to
breast cancer are lower in developed countries than in developing countries.
It is known that breast self-examination, clinical breast examination and mammography play an
important role in making an early diagnosis of breast cancer. The uptake rate for mammography
performed on a regular basis is low because this is an expensive method, considering that not
all individuals have health insurance and public funding is inadequate, especially in
developing countries. Hence, breast self-examination (which has no cost) and clinical breast
examination (which only has low cost) remain important diagnostic methods. Moreover, during
clinical breast examination, healthcare professionals have the opportunity to advise on
breast cancer, risk factors, prevention methods and screening methods.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |